 ccording
to a recent analysis of
Essential Science Indicators
data, the Journal of Cellular and Molecular Medicine
is having a significant impact in the field of Clinical Medicine
(see New Entrants).
The journal’s current citation statistics include 334 highly
cited papers with a total of 2,675 citations. The Journal of
Cellular and Molecular Medicine is published by
Blackwell Publishing in association with the Foundation for
Cellular and Molecular Medicine. In the interview below,
Editor-in-Chief Professor L.M. Popescu talks with us about the
journal’s citation achievements |
Did you expect the Journal of
Cellular & Molecular Medicine to become highly cited, or is this
surprising to you?
|
 |
|
|
“In our opinion, such a success story could
be not possible without the advantages provided by the
Internet...” |
|
|
Yes, we expected to have a significant increase—in fact, we
were monitoring the intermediary impact-factor-analyzing data
currently updated weekly on the Web of Science.
How would you account for the increased citation rate of the
Journal of Cellular & Molecular Medicine?
The increase in the citation rate of JCMM was the
result of a better and better application of the criteria for
reviewing the manuscripts (see Academic Medicine 2001).
Instead of rejecting papers by default, when minor (or major)
issues were reported by reviewers, our policy was to provide the
opportunity to improve manuscripts. Sometimes, even good
manuscripts were proven to be susceptible to becoming even
better. Instead of applying the rule "reject" we applied the
rule "improve (if possible and if it is worthy!)." As a result,
good papers were cited more readily.
Was there a change in policy or editorial direction that might
account for this?
No, there was not a change in policy or editorial direction;
on the contrary, a sustained effort was to maintain a direction:
to constantly improve aspects concerning scientific revision and
a rigorous selection of the invited papers (reviews or
comments).
What historical factors have contributed to the success of the
Journal of Cellular & Molecular Medicine?
In our opinion, such a success story could be not possible
without the advantages provided by the Internet: support for
manuscript submissions, correspondence with reviewers, and, not
least, the free-of-charge access for the online version!
Have there been specific developments in the fields served by the
Journal of Cellular & Molecular Medicine that may have
contributed?
One may observe that we are currently publishing some Review
Series, with Guest Editors (e.g. tissue engineering, stem cells,
interstitial Cajal-like cells etc). Some very good reviews may
have contributed significantly.
What, in your view, is this journal's main significance or
contribution in the field of Clinical Medicine?
Being a translational journal, filling the gap between bench
and the bedside.
What role do you see for your journal in the next few years?
To maintain the position currently obtained and to become a
well-known and respected scientific brand joining basic science
and clinical knowledge.
Journal of Cellular & Molecular Medicine
L.M. Popescu, M.D., Ph.D., Editor-in-Chief
Blackwell Publishing, publisher, in association with the Foundation
for Cellular and Molecular Medicine
| Journal of Cellular and Molecular Medicine's
most-cited paper with 111 cites to date: |
|
Song G, Ouyang
GL, Bao SD, "The activation of AKT/PKB siganling pathway and
cell survival," J. Cell. Mol. Med. 9(1): 59-71,
Jan-Mar 2005. |
|
Source:
Essential Science Indicators |
|
|
cites
